Cellino
Matthias Wagner is the Co-Founder and CTO of Cellino, a company that specializes in building all-optical platforms for patient-specific cell and tissue manufacturing. Prior to Cellino, Matthias was the Owner of 1087systems, a company that developed platforms and IP portfolios for mid-infrared spectroscopic measurements in microfluidic formats. Matthias has also served as an Advisor/Consultant for various hardware, imaging, and materials companies. Throughout their career, Matthias has been focused on developing new technologies and products that can improve the lives of people around the world.
Matthias Wagner attended the Lawrenceville School from 1983 to 1988. Matthias then went on to Harvard University where they studied engineering and physics from 1988 to 1992. After working for a few years, they decided to further their education and attended the MIT Sloan School of Management from 1996 to 1998, where they obtained their MBA in finance.
This person is not in any offices
Cellino
Cellino is an autologous regenerative medicine company developing an AI-guided single-cell laser editing platform for cell-based therapies. The company has developed a scalable platform that automates and standardizes autologous stem cell production, accelerating the development of life-saving medicines for patients. Cellino is based in Cambridge, MA.